Colon & Rectal Cancer
Treatment Options
If you have colon or rectal cancer, call us. We can help you review the stage, biomarkers, treatment history and options that are available.
Newly diagnosed, in treatment, facing recurrence or Stage 4 disease—your case deserves an individualized review, not a one-size-fits-all protocol.
Call 1.800.923.7878The introductory call with our Patient Care Team is free. Medical recommendations require a physician consultation.
Talk With Our Colorectal Cancer Patient Care Team
Tell us what you are facing. Our Patient Care Team will follow up personally and explain the next step. The introductory call is free.
A clearer way to understand your treatment options
A colorectal cancer diagnosis can produce a stack of pathology reports, scans and urgent decisions. Sunridge begins by reviewing the individual case: where the cancer started, how far it has spread, what the pathology and biomarkers show, what treatment has already been tried, how the patient is tolerating it and what the patient wants help with now.
People comparing colon cancer treatment options or rectal cancer treatment options need more than a generic list. The relevant choices depend on the primary site, stage, resectability, tumor biology, prior response and the individual patient.
Colon cancer, rectal cancer and “bowel cancer” are not interchangeable search terms
Colon cancer
Colon cancer begins in the large intestine above the rectum. For many localized colon cancers, surgery is the central treatment. Additional therapy depends on stage, lymph-node involvement, pathology features, biomarkers and the risk of recurrence.
Rectal cancer
Rectal cancer begins in the final portion of the large intestine. Because of its location in the pelvis, treatment may involve a different sequence of chemotherapy, radiation and surgery. Preserving function and planning the order of care can be especially important.
“Colorectal cancer” includes both colon and rectal cancers. “Bowel cancer” is another term patients may encounter, especially outside the United States. An accurate site and pathology review should come before any discussion of conventional, complementary, integrative or alternative treatment.
The stage is important, but it is not the whole plan
Define the extent
Review the primary tumor, regional lymph nodes and every known site of spread. Limited liver or lung metastases can present different decisions from widespread metastatic disease.
Review the biology
MMR/MSI, KRAS, NRAS, BRAF and other findings may influence whether immunotherapy or particular targeted approaches are relevant.
Review the person
Prior treatment, blood counts, kidney and liver function, nutrition, neuropathy, other conditions, medications and goals all affect what is reasonable.
Common treatment categories
Depending on the exact case, care may include surgery, systemic chemotherapy, radiation (particularly for rectal cancer), targeted therapy, immunotherapy for selected biomarker-defined tumors, clinical trials, ablation or other local treatment of limited metastases, symptom management and supportive care. A page or advertisement cannot determine which of these is appropriate for an individual patient.
What “alternatives to chemotherapy” can safely mean
People often reach this page after searching for alternative colon cancer treatment, holistic colorectal care, natural cancer treatment or a way to avoid difficult chemotherapy side effects. Those searches reflect real concerns, but the terms can be misleading.
There may be legitimate alternatives in a treatment pathway
For example, surgery may be the primary treatment for a localized colon cancer. Radiation has a larger role in many rectal cancers. Immunotherapy can be important for certain MSI-high or mismatch-repair-deficient cancers. Selected metastases may be considered for local treatment. These are medical decisions driven by stage and biology—not broad promises to “skip chemotherapy.”
Integrative care should have a defined purpose
Support may focus on nutrition, strength, hydration, sleep, treatment tolerance, symptom relief, medication and supplement interactions, or quality of life. A therapy shown to help a symptom should not be described as though it controls the cancer.
No herb, diet or supplement has been proven to cure colorectal cancer or prevent recurrence. Natural products can also interact with chemotherapy, radiation, immunotherapy, anticoagulants and other medications. A careful review matters.
Biomarkers can change the questions worth asking
Molecular and biomarker testing has made “colon cancer” a less complete description than it once was. Depending on the stage and clinical situation, a care team may review mismatch repair or microsatellite instability (dMMR/MSI-H), KRAS and NRAS, BRAF and other alterations. These results can affect treatment eligibility, suggest hereditary evaluation or help explain why a particular targeted therapy is or is not expected to help.
- MMR/MSI status and whether immunotherapy is relevant
- KRAS and NRAS status when EGFR-directed treatment is being considered
- BRAF V600E and other potentially actionable findings
- Whether tumor tissue, a blood-based assay or repeat testing is appropriate
- Whether genetic counseling or germline testing should be discussed
- Whether the current report is complete for the present stage of disease
New diagnosis, Stage 3, Stage 4 and recurrence require different conversations
Stage 3
Stage 3 generally means regional lymph nodes are involved without known distant metastasis. Surgery and postoperative treatment decisions often depend on the exact pathologic risk, recovery, timing and ability to tolerate therapy.
Stage 4 / metastatic
Stage 4 colorectal cancer is not one single situation. The number and location of metastases, whether they can be treated locally, tumor biology, symptoms, treatment history and response all matter.
Liver metastases
The liver is a common site of spread. Selected patients may need review by teams experienced in systemic therapy, liver surgery, ablation, radiation or other liver-directed approaches.
Recurrence
A recurrence deserves a fresh review of pathology, imaging, biomarkers, previous treatment and the reason each prior therapy was stopped. Progression does not make every case identical.
Survival statistics cannot predict an individual patient
People searching for Stage 4 colon cancer survival, colon cancer prognosis, a colorectal cancer specialist or a colon cancer oncologist are usually trying to answer the same urgent question: “What does this diagnosis mean for me?” Population survival estimates describe groups treated in the past. They do not account fully for a particular patient’s disease pattern, molecular profile, response to treatment, local-treatment opportunities, overall health or newer therapies.
Ask what drives the estimate
The primary site, stage, number and location of metastases, symptoms, laboratory findings, biomarkers, treatment response and whether all visible disease can be treated locally can change the clinical outlook.
Ask which expertise is needed
A case may benefit from medical oncology, colorectal surgery, radiation oncology, liver or lung expertise, pathology, genetics, nutrition, supportive care or clinical-trial review. Sunridge in Scottsdale can provide an integrative physician review and coordinate questions with the patient’s established cancer team when appropriate.
A responsible second opinion should explain uncertainty, not sell certainty. No clinic can guarantee a cure, a survival time or a particular response.
What to gather before the conversation
A useful colorectal cancer review is more than a quick look at the diagnosis name. If available, gather the records below. Missing records should not prevent you from calling; our Patient Care Team can explain what is most helpful.
- Pathology and operative reports
- Recent CT, MRI or PET reports and image files
- Colonoscopy and endoscopy reports
- Chemotherapy, radiation and surgery history
- MMR/MSI and molecular testing reports
- Recent blood work, including liver and kidney function
- Current medication and supplement list
- A short timeline of response, side effects and progression
Talk with our Patient Care Team for free
If you are facing colon or rectal cancer, you do not have to sort through the reports and options alone. Tell us what you are facing. We can explain the consultation process and help you decide whether a physician review at Sunridge may be an appropriate next step.
Explore the question that fits your situation
Frequently asked questions
Is colon cancer the same as rectal cancer?
They are closely related and collectively called colorectal cancer, but location can change treatment. Radiation and preoperative treatment have a larger role in many rectal cancers than in typical colon cancers.
Can Stage 4 colon cancer be treated?
Stage 4 colorectal cancer is treatable, although the goals and options vary widely. Systemic therapy, biomarker-directed treatment, surgery or local treatment of selected metastases, clinical trials and supportive care may be considered after individual review.
Does “alternative treatment” mean stopping chemotherapy?
No. Sometimes there are medically appropriate alternatives or a different treatment sequence, but that depends on stage, site, biomarkers and prior response. Integrative care can also be used alongside conventional treatment. Never stop prescribed treatment without discussing it with the treating team.
When is immunotherapy used for colorectal cancer?
Immunotherapy is especially relevant to certain tumors with mismatch-repair deficiency or high microsatellite instability. Other factors and treatment settings matter, so a biomarker result must be interpreted in the full clinical context.
What makes a second opinion useful?
A second opinion can confirm the diagnosis and stage, review biomarker testing, consider the sequence of surgery and systemic treatment, identify local treatment opportunities or clinical trials, and clarify the goals and tradeoffs of available choices.
Is the introductory call free?
Yes. The introductory conversation with the Patient Care Team is free. It is not a medical consultation or diagnosis; it helps you understand the process and whether a physician review may be appropriate.
Sources and important context
- Colon Cancer Treatment (PDQ®)
- Rectal Cancer Treatment (PDQ®)
- Biomarker Testing for Cancer Treatment
- Finding Cancer Care and Seeking a Second Opinion
- Cancer Therapy Interactions With Foods and Dietary Supplements
Medical information disclaimer: This page is for general education and does not replace individualized medical advice, diagnosis or treatment. Colorectal cancer decisions require review of the exact diagnosis, primary site, stage, pathology, biomarkers, prior therapy, medications and overall health. Do not start, stop or replace cancer treatment based on website content.
Integrative Colorectal Cancer Care in Scottsdale, Arizona
Sunridge Medical provides physician-directed integrative support for people facing colorectal cancer at our Scottsdale clinic. We serve patients from Scottsdale, Phoenix, the Greater Phoenix area and people traveling to Arizona for care.
Planning can integrate tumor location, stage, molecular findings, surgery, systemic treatment, digestive function, nutrition and recovery goals.
14200 N Northsight Blvd, Suite 160
Scottsdale, Arizona 85260
Map, parking and directions →
Call 1-800-923-7878 for a free introductory conversation about your diagnosis and next steps.
Our team can help you understand scheduling and plan a visit to the Scottsdale clinic.